Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $79000.0.

  • InfuSystem Holdings' Capital Expenditures rose 8372.09% to $79000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 2865.98%. This contributed to the annual value of $1.4 million for FY2024, which is 3505.86% up from last year.
  • Latest data reveals that InfuSystem Holdings reported Capital Expenditures of $79000.0 as of Q3 2025, which was up 8372.09% from $217000.0 recorded in Q2 2025.
  • InfuSystem Holdings' Capital Expenditures' 5-year high stood at $1.3 million during Q4 2022, with a 5-year trough of $43000.0 in Q3 2024.
  • Moreover, its 5-year median value for Capital Expenditures was $196000.0 (2021), whereas its average is $332947.4.
  • Examining YoY changes over the last 5 years, InfuSystem Holdings' Capital Expenditures showed a top increase of 32925.76% in 2021 and a maximum decrease of 7391.3% in 2021.
  • InfuSystem Holdings' Capital Expenditures (Quarter) stood at $983000.0 in 2021, then skyrocketed by 35.4% to $1.3 million in 2022, then crashed by 69.35% to $408000.0 in 2023, then surged by 101.23% to $821000.0 in 2024, then crashed by 90.38% to $79000.0 in 2025.
  • Its Capital Expenditures was $79000.0 in Q3 2025, compared to $217000.0 in Q2 2025 and $131000.0 in Q1 2025.